...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Development and validation of a simple and sensitive liquid chromatography-tandem mass spectrometry method for quantifying trimetazidine in human plasma.
【24h】

Development and validation of a simple and sensitive liquid chromatography-tandem mass spectrometry method for quantifying trimetazidine in human plasma.

机译:开发和验证一种简单灵敏的液相色谱-串联质谱法定量人血浆中的曲美他嗪。

获取原文
获取原文并翻译 | 示例
           

摘要

1. A simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for quantifying trimetazidine in human plasma was developed and validated. Sample preparation was based on deproteinating with acetonitrile. 2. Chromatography was performed on a C18 analytical column (5 mum; 150 x 2.1 mm i.d.) and the retention times for trimetazidine and cetirizine (used as the internal standard) were 1.8 and 3.0 min, respectively. The ionization was optimized using an electrospray ionization source and enhanced selectivity was achieved using tandem mass spectrometry. The calibration curve ranged from 0.1 to 200 ng/mL. The inter-day precision, accuracy and the relative standard deviation (RSD) were all < 15%. The analyte was shown to be stable over the time-scale of the entire procedure. 3. The robustness of the method was demonstrated by the good reproducibility of the results obtained during the analysis of clinical samples.
机译:1.建立并验证了一种简单灵敏的液相色谱-串联质谱(LC-MS-MS)方法定量人血浆中的曲美他嗪。样品制备基于乙腈脱蛋白。 2.在C18分析柱(5毫米; 150 x 2.1毫米内径)上进行色谱分析,曲美他嗪和西替利嗪(用作内标)的保留时间分别为1.8分钟和3.0分钟。使用电喷雾电离源优化电离,并使用串联质谱法提高选择性。校准曲线的范围为0.1到200 ng / mL。日间精度,准确性和相对标准偏差(RSD)均<15%。结果表明,在整个过程中,分析物都是稳定的。 3.通过在临床样品分析过程中获得的结果具有良好的可重复性,证明了该方法的鲁棒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号